Engineered cells take drugs deep into the brain and nowhere else
Engineered T cells can deliver drugs directly to brain tumors by crossing the blood-brain barrier.
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas - Nature
CAR T-cell therapy may offer new hope in treating H3K27M-mutated diffuse midline gliomas with targeted GD2-CAR T-cells.
'A brain tumour the size of a tennis ball came out my eyebrow'
A pioneering eyebrow surgery for large brain tumours in Scotland reduces recovery time and complications, revolutionizing traditional neurosurgical methods.
Molecular Profiling May Improve Meningioma Decisionmaking - News Center
Molecular profiling of meningiomas can predict treatment response and improve patient outcomes.
Investigators Discover New Therapeutic Target for Pediatric Brain Cancers - News Center
Targeting TIM3 protein may enhance survival in pediatric brain cancer treatments, specifically low-grade astrocytoma, presenting a potential new therapeutic option.